Takeda: all 1,753 studies

Page 4 of 18. Open to participants first (93), then studies with results posted, then the rest; newest registration first within each.

• A Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability of TAK-788 Followed by Evaluation of the Effects of a Low-Fat Meal on TAK-788 PK and Evaluation of Relative Bioavailability of TAK-788 Capsules in Healthy ParticipantsCompletedNCT03482453Phase 1Results posted
• TAK-954 in Critically Ill Participants With Enteral Feeding Intolerance (EFI)TerminatedNCT03477903Phase 2Results posted
• Actovegin 12-Week Treatment Given First Intravenously and Subsequently Orally in Participants With Peripheral Arterial Occlusive Disease Fontaine Stage IIBCompletedNCT03469349Phase 3Results posted
• A Study to Evaluate the Bioequivalence (BE) and the Food Effect of TAK-438ASA TabletCompletedNCT03456960Phase 1Results posted
• A Study of TAK-164 in Participants With Advanced Gastrointestinal (GI) Cancer Expressing Guanylyl Cyclase C (GCC)TerminatedNCT03449030Phase 1Results posted
• A Study of Ixazomib+Daratumumab+Dexamethasone (IDd) in Relapsed and/or Refractory Multiple Myeloma (RRMM)CompletedNCT03439293Phase 2Results posted
• A Study to Investigate the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of TAK-079 Administered Subcutaneously as a Single Agent in Participants With Relapsed/Refractory (r/r) Multiple Myeloma (MM)CompletedNCT03439280Phase 1/2Results posted
• A Bioequivalence Study of the Lu AA21004 20 mg and 2×10 mg TabletsCompletedNCT03437564Phase 1Results posted
• A Phase 1 Food Effect Study of Azilsartan (TAK-536) Pediatric FormulationCompletedNCT03434977Phase 1Results posted
• A Study in Relapsed and/or Refractory Multiple Myeloma Patients Treated With Ixazomib Plus Lenalidomide and DexamethasoneCompletedNCT03433001Results posted
• Lot-to-lot Consistency of 3 Lots of Tetravalent Dengue Vaccine (TDV) in Non-endemic Country(Ies) for DengueCompletedNCT03423173Phase 3Results posted
• A Phase 1 Drug-Drug Interaction Study Between Brigatinib and the CYP3A Substrate, Midazolam, in Participants With ALK-Positive or ROS1-Positive Solid TumorsCompletedNCT03420742Phase 1Results posted
• A Study to Evaluate the Efficacy and Safety of Ixazomib in Combination With Lenalidomide and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma Initially Treated With an Injection of Proteasome Inhibitor-Based TherapyCompletedNCT03416374Phase 4Results posted
• Phase 2 Study of Brigatinib in Japanese Participants With Anaplastic Lymphoma Kinase (ALK)-Positive Non-Small Cell Lung Cancer (NSCLC)CompletedNCT03410108Phase 2Results posted
• Assessment of Immune Activation and Tolerance in Celiac Disease During Gluten ChallengeCompletedNCT03409796Not applicableResults posted
• Study of Lanadelumab in Healthy Japanese and Matched Caucasian Adult SubjectsCompletedNCT03401671Phase 1Results posted
• A Study of BAX 930 in Children, Teenagers, and Adults Born With Thrombotic Thrombocytopenic Purpura (TTP)CompletedNCT03393975Phase 3Results posted
• A Phase 4 Post-marketing Study of Intramuscular Injections of BLB-750 in Healthy Adult SubjectsCompletedNCT03370289Phase 4Results posted
• A Study of BAX 888 in Male Adults With Severe Hemophilia ACompletedNCT03370172Phase 1/2Results posted
• Safety and Efficacy Study of rhPTH(1-84) in Subjects With HypoparathyroidismTerminatedNCT03364738Phase 3Results posted
• Safety, Immunogenicity, and Dose Ranging Study of Inactivated Zika Virus Vaccine in Healthy ParticipantsCompletedNCT03343626Phase 1Results posted
• Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) Administered With a Yellow Fever Vaccine in AdultsCompletedNCT03342898Phase 3Results posted
• Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) in Adolescents in Non-Endemic Area(s)CompletedNCT03341637Phase 3Results posted
• A Phase 2 Study of Cabozantinib in Japanese Participants With Advanced Renal Cell CarcinomaCompletedNCT03339219Phase 2Results posted
• Open-label Study of Midazolam Hydrochloride Oromucosal Solution (MHOS/SHP615) in Children With Status Epilepticus (Convulsive) in a Healthcare Setting in JapanCompletedNCT03336645Phase 3Results posted
• Study of Midazolam Hydrochloride Oromucosal Solution (MHOS/SHP615) in Pediatric Patients With Status Epilepticus (Convulsive) in the Community SettingCompletedNCT03336450Phase 3Results posted
• Phase 1 TAK-925 Study in Healthy Adult and Elderly Volunteers and Participants With NarcolepsyCompletedNCT03332784Phase 1Results posted
• A Study to Evaluate the Effects of Pevonedistat on the Corrected QT (QTc) Interval in Participants With Advanced Solid TumorsCompletedNCT03330106Phase 1Results posted
• A Study to Determine the Pharmacokinetics (PK) of Single Intravenous (IV) Dose of Vedolizumab 300 Milligram (mg) in Healthy Adult Chinese ParticipantsCompletedNCT03329209Phase 1Results posted
• B-CD30 + Hodgkin Lymphoma International Multi-center Retrospective Study of Treatment Practices and OutcomesCompletedNCT03327571Results posted
• Safety, Tolerability and Pharmacokinetics of SHP465 in Children Aged 4 to 5 Years With Attention-Deficit/Hyperactivity Disorder (ADHD)CompletedNCT03327402Phase 1Results posted
• Safety and Tolerability Study of SHP465 in Children Aged 4 to 12 Years Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD)TerminatedNCT03325894Phase 3Results posted
• Efficacy and Safety of SHP465 at 6.25 mg in the Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in Children Aged 6-12 YearsCompletedNCT03325881Phase 3Results posted
• A Study to Learn if Recombinant Human Parathyroid Hormone [rhPTH(1-84)] Can Improve Symptoms and Metabolic Control in Adults With Hypoparathyroidism (BALANCE)CompletedNCT03324880Phase 4Results posted
• A Study to Evaluate the Pharmacokinetics of Dexlansoprazole 30 Milligram (mg) and 60 mg Delayed-release Capsules in Healthy Chinese ParticipantsCompletedNCT03316976Phase 1Results posted
• A Study to Evaluate the Effect of Renal Impairment and Dialysis Treatment on the Pharmacokinetics (PK) of a Single Intravenous (IV) TAK-954CompletedNCT03296787Phase 1Results posted
• An Efficacy and Safety Study of Ontamalimab as Maintenance Therapy in Participants With Moderate to Severe Ulcerative ColitisCompletedNCT03290781Phase 3Results posted
• A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)CompletedNCT03283085Phase 3Results posted
• Effect of TAK-954 on Gastrointestinal and Colonic Transit in Diabetic or Idiopathic Gastroparesis ParticipantsCompletedNCT03281577Phase 2Results posted
• Study to Assess Efficacy and Safety of Cx601, Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Participants With Crohn's Disease (CD)CompletedNCT03279081Phase 3Results posted
• Efficacy, Safety, Tolerability, Immunogenicity and Pharmacokinetic Evaluation of HYQVIA in Pediatric PIDD SubjectsCompletedNCT03277313Phase 3Results posted
• A Study to Evaluate the Effect of Hepatic Impairment on the Single Dose Pharmacokinetics (PK) of Intravenous TAK-954CompletedNCT03277274Phase 1Results posted
• Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)CompletedNCT03268954Phase 3Results posted
• A Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) for TAK-906 in Participants With Diabetes Mellitus and Gastroparesis (DG) or With Idiopathic Gastroparesis (IG)CompletedNCT03268941Phase 2Results posted
• A Study in Japanese Children With Short Bowel Syndrome Who Completed SHP633-302CompletedNCT03268811Phase 3Results posted
• A Study to Evaluate the Safety, Tolerability, and Activity of TAK-931 in Participants With Metastatic Pancreatic Cancer, Metastatic Colorectal Cancer, and Other Advanced Solid TumorsCompletedNCT03261947Phase 2Results posted
• Safety and Efficacy Study in Preschool Children Aged 4-5 Years With Attention-deficit/Hyperactivity Disorder (ADHD)CompletedNCT03260205Phase 3Results posted
• Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative ColitisTerminatedNCT03259334Phase 3Results posted
• Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative ColitisTerminatedNCT03259308Phase 3Results posted
• Continuation Study With Budesonide Oral Suspension (BOS) for Adolescent and Adult Participants With Eosinophilic Esophagitis (EoE)TerminatedNCT03245840Phase 3Results posted
• Phase 1 TAK-906 Single and Multiple Ascending Dose Study in Japanese Healthy Male ParticipantsCompletedNCT03237156Phase 1Results posted
• Vedolizumab Intravenous (IV) Compared to Placebo in Chinese Participants With Crohn's Disease.CompletedNCT03234907Phase 3Results posted
• Treatment Preference for Weekly Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Versus Daily DPP-4 Inhibitors in Participants With Type 2 Diabetes MellitusCompletedNCT03231709Phase 4Results posted
• A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Ascending Oral Single Dose of TAK-418 in Healthy ParticipantsCompletedNCT03228433Phase 1Results posted
• Drug Use Surveillance of Takecab for "Supplement to Helicobacter Pylori Eradication"CompletedNCT03219723Results posted
• Drug Use Surveillance of Vonoprazan for "Gastric Ulcer, Duodenal Ulcer, and Reflux Esophagitis"CompletedNCT03214952Results posted
• Special Drug Use Surveillance of Vonoprazan for "Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs: Long-term Use"CompletedNCT03214198Results posted
• Special Drug Use Surveillance of Vonoprazan for "Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Low-dose Aspirin: Long-term Use"CompletedNCT03214094Results posted
• Special Drug Use Surveillance of Vonoprazan for "Maintenance Therapy of Reflux Esophagitis: Long-term Use"CompletedNCT03214081Results posted
• Special Drug Use Surveillance of Leuprorelin for Injection Kit 22.5 mg in "Premenopausal Breast Cancer"CompletedNCT03209518Results posted
• Special Drug Use Surveillance of Leuplin PRO for Injection Kit 22.5 mg for "Prostate Cancer"CompletedNCT03209492Results posted
• Long-term Safety With Vedolizumab Intravenous (IV) in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD)CompletedNCT03196427Phase 2Results posted
• Clinical and Sociodemographic Characterization of Multiple Myeloma Participants With Symptomatic Relapse and/or Refractory Disease in Spain (CharisMMa Study)CompletedNCT03188536Results posted
• A Study to Evaluate the Effect of the Potent Cytochrome P-450 3A4 (CYP3A4) Inhibitor Itraconazole on the Pharmacokinetics (PK) of TAK-954 in Healthy Adult ParticipantsCompletedNCT03173170Phase 1Results posted
• A Study of Ixazomib, Given With Dexamethasone in Adults With Multiple MyelomaCompletedNCT03170882Phase 2Results posted
• ADYNOVATE Drug Use-Results SurveyCompletedNCT03169972Results posted
• NINLARO Capsules Drug Use-Results Survey (All-Case Surveillance) "Relapsed/Refractory Multiple Myeloma"CompletedNCT03169361Results posted
• Study of TAK-935 as an Adjunctive Therapy in Participants With Developmental and/or Epileptic EncephalopathiesCompletedNCT03166215Phase 1/2Results posted
• A Study to Evaluate the Effect of the Potent CYP3A4 Inhibitor Itraconazole on the Pharmacokinetics (PK) of TAK-906 in Healthy ParticipantsCompletedNCT03161405Phase 1Results posted
• Cx611-0204 SEPCELL StudyCompletedNCT03158727Phase 1/2Results posted
• Study of rhPTH(1-84) in Japanese Healthy Subjects Compared With Matched Caucasian Healthy Adult SubjectsCompletedNCT03150108Phase 1Results posted
• Vedolizumab IV in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD)CompletedNCT03138655Phase 2Results posted
• Bioequivalence Study of Dexlansoprazole Capsules From Two Manufacturing PlantsCompletedNCT03131895Phase 1Results posted
• Study of SHP639 Eye Drops in Adults With High Eye Pressure or Primary Open-angle GlaucomaCompletedNCT03131167Phase 1Results posted
• Vonoprazan Study of Investigating the Effect on Sleep Disturbance Associated With Reflux Esophagitis- Exploratory EvaluationCompletedNCT03116841Phase 4Results posted
• Post-Authorization Safety, Tolerability and Immunogenicity Evaluation of HyQvia in Pediatric PIDD SubjectsCompletedNCT03116347Phase 4Results posted
• IPV-102 Safety, Tolerability and Immunogenicity of TAK-195 in Healthy Infants, Toddlers and AdultsTerminatedNCT03092791Phase 1/2Results posted
• A Pharmacokinetic Study of TAK-438 in Healthy Adult Chinese ParticipantsCompletedNCT03085836Phase 1Results posted
• A Study to Evaluate the Bioequivalence of Single Oral Dose of Esomeprazole Capsule and Tablet Formulation in Healthy ParticipantsCompletedNCT03083639Phase 1Results posted
• Cognitive and Mood Assessment Data in Major Depressive Disorder Using Digital Wearable TechnologyCompletedNCT03067506Results posted
• A Study of [14 C]-Pevonedistat in Participants With Advanced Solid TumorsCompletedNCT03057366Phase 1Results posted
• Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Duodenal Ulcer Participants With or Without Helicobacter Pylori InfectionCompletedNCT03050359Phase 3Results posted
• Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Gastric Ulcer Participants With or Without Helicobacter Pylori InfectionCompletedNCT03050307Phase 3Results posted
• A Phase 1, Bio-equivalence Study of TAK-536 Pediatric FormulationCompletedNCT03042299Phase 1Results posted
• Long-Term Immunogenicity of the Norovirus GI.1/GII.4 Bivalent Virus-like Particle (VLP) Vaccine (NoV Vaccine) in AdultsCompletedNCT03039790Phase 2Results posted
• Vedolizumab Intravenous (IV) Dose Optimization in Ulcerative ColitisCompletedNCT03029143Phase 4Results posted
• Study of the QOL Evaluation of Trelagliptin in Patients With Type 2 Diabetes MellitusCompletedNCT03014479Phase 4Results posted
• Treatment of Bacterial Conjunctivitis With SHP640 Compared to PVP-Iodine and PlaceboCompletedNCT03004924Phase 3Results posted
• Treatment of Adenoviral Conjunctivitis With SHP640 Compared to PlaceboTerminatedNCT02998554Phase 3Results posted
• Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Povidone-iodine (PVP-I) and PlaceboTerminatedNCT02998541Phase 3Results posted
• A Study to Assess the Safety and Efficacy of Enantone (Leuprorelin) in Central Precocious Puberty (CPP) Among Chinese ParticipantsCompletedNCT02993926Results posted
• A Dose-Finding Study of Vedolizumab for Treatment of Steroid-Refractory Acute Intestinal Graft-Versus-Host Disease (GvHD) in Participants Who Have Undergone Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT)TerminatedNCT02993783Phase 2Results posted
• Non-Interventional Study of the Use of Alogliptin and Alogliptin Fixed-Dose Combinations With Pioglitazone and With Metformin in Standard Clinical PracticeTerminatedNCT02989649Results posted
• Study in Japanese Pediatric Subjects With Short Bowel Syndrome (SBS) Who Are Dependent on Parenteral SupportCompletedNCT02980666Phase 3Results posted
• A Study of Brentuximab Vedotin + Adriamycin, Vinblastine, and Dacarbazine in Pediatric Participants With Advanced Stage Newly Diagnosed Hodgkin LymphomaActive, not recruitingNCT02979522Phase 1/2Results posted
• rVWF IN PROPHYLAXISCompletedNCT02973087Phase 3Results posted
• Goal Achievement After a Change to Vortioxetine in Adults With Major Depressive DisorderCompletedNCT02972632Phase 4Results posted
• Epidemiologic Study Of Diabetes And Cancer RiskCompletedNCT02958995Results posted
• Cohort Study of Pioglitazone and Cancer Incidence in Participants With Diabetes Mellitus.CompletedNCT02958956Results posted
• A Phase 2/3 Study of GLASSIA for the Treatment of Acute GvHDTerminatedNCT02956122Phase 2/3Results posted

← Takeda overview and focus areas